glp 1 agonist alzheimer GLP-1R agonists protect against Alzheimer's disease by rewiring energy regulation Neuroprotective Actions of Glucagon-Like Peptide-1

Glucagon-like peptide-1 (GLP-1) receptor agonists are medications approved by the FDA for managing type 2 diabetes and, in some formulations, for chronic weight management

ja.ma/4o96Ktr Postpartum prescription of #GLP-1RAs in Denmark increased between 2018 and 2024, with #semaglutide accounting for most prescriptions since 2023

The next step in diagnosing drug-induced pancreatitis requires ruling out more common etiologies such as gallstone pancreatitis and ethanol-induced acute pancreatitis

"Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain"

The drugs also warn about side effects like pancreatitis, diabetic retinopathy, low blood sugar, kidney problems, allergic reactions and sudden gallbladder disease